Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | LLY:NYQ since announced | Transaction value |
|---|---|---|
| Ventyx Biosciences Inc | -0.55% | 1.01bn |
| Adverum Biotechnologies Inc | 28.88% | 274.32m |
| Verve Therapeutics Inc | 31.03% | 1.25bn |
| SiteOne Therapeutics Inc | 48.26% | 1.00bn |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
